Journals / Journal of Research in Veterinary Medicine / 2020 / Cilt: 39 - Sayı: 2

Acute Effect of Centrally Injected Nesfatin-1 on Some Blood Electrolytes and Metabolites in Rats

Pages
149–152
Publication Date
2020-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, our findings show that the central nesfatin-1 could affect the concentrations of blood glucose, lactate, hematocrit, and hemoglobin without altering the blood electrolytes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nesfatin-1 is a newly found food and water intake regulatory neuropeptide.
📊
Key Findings & Data:Because it can regulate nutrition and thirst, nesfatin-1 may also have the potential to affect levels of blood electrolytes and metabolites.
💡
Conclusion & Impact:In conclusion, our findings show that the central nesfatin-1 could affect the concentrations of blood glucose, lactate, hematocrit, and hemoglobin without altering the blood electrolytes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nesfatin-1 · Intracerebroventricular · Blood electrolytes

Abstract

Nesfatin-1 is a newly found food and water intake regulatory neuropeptide. Because it can regulate nutrition and thirst, nesfatin-1 may also have the potential to affect levels of blood electrolytes and metabolites. The current study was intended to resolve the acute influence of intracerebroventricularly injected nesfatin-1 on the levels of some blood electrolytes and metabolites in rats. The experiments were conducted on Sprague Dawley male rats. Nesfatin-1 (200 pmol) or saline (5 μL) was given the rats intracerebroventricularly. Central nesfatin-1 treatment caused increases in the concentrations of blood glucose, lactate, hematocrit, and hemoglobin without changing the blood pH, creatine, Na, K, Ca, Cl, and HCO3 levels. In conclusion, our findings show that the central nesfatin-1 could affect the concentrations of blood glucose, lactate, hematocrit, and hemoglobin without altering the blood electrolytes. This could be interpreted as the secondary effect of nesfatin-1 as a consequence of centrally injected nesfatin-1-evoked activation of sympathetic nerves.

🔖

Cite This Article

BAYRAM, G. G., ÜLGER, E. Y., YALÇIN, M. (2020). Acute Effect of Centrally Injected Nesfatin-1 on Some Blood Electrolytes and Metabolites in Rats. Journal of Research in Veterinary Medicine, Cilt: 39 - Sayı: 2, 149–152. https://ajindex.com/articles/778564

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Schalla MA, Stengel A. Current Understanding of the Role of Nesfatin-1. J Endocr. Soc. 2018;2:1188-1206.
  2. Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709–712
  3. Yilmaz MS, Altinbas B, Guvenc G, et al. The role of centrally injected nesfatin-1 on cardiovascular regulation in normotensive and hypotensive rats. Auton. Neurosci. 2015;193:63-68.
  4. Aydin B, Guvenc G, Altinbas B, et al. Modulation of nesfatin-1-induced cardiovascular effects by the central cholinergic system. Neuropeptides 2018;70:9-15.
  5. Ciftci K, Guvenc G, Bas A, et al. Effect of central and peripheral ınjected nesfatin-1 on electrocardiography in rats. J. Res. Vet. Med. 2019;38:10-17.
  6. Ciftci K, Guvenc G, Kasikci E, et al. Centrally and peripherally injected nesfatin-1-evoked respiratory responses. Respir. Physiol. Neurobiol. 2019;267:6-11.
  7. Guvenc G, Altinbas B, Kasikci E, et al. Contingent role of phoenixin and nesfatin-1 on secretions of the male reproductive hormones. Andrologia. 2019;51:e13410. Stengel A, Goebel M, Yakubov I, et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology. 2009;150:232–238.
  8. Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology. 2010;151:3169–3180.
  9. Gonzalez R, Tiwari A, Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem. Biophys. Res. Commun. 2009;381:643–648.
  10. Garcia-Galiano D, Pineda R, Ilhan T, et al. Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1 in the testis. Endocrinology. 2012;153:1959–1971.
  11. Gonzalez R, Shepperd E, Thiruppugazh V, et al. Nesfatin-1 regulates the hypothalamo-pituitary-ovarian axis of fish. Biol. Reprod. 2012;87:84. Kim J, Chung Y, Kim H, et al. The tissue distribution of nesfatin-1/NUCB2 in mouse. Dev. Reprod. 2014;18:301–309.
  12. Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, et al. Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4. Endocrinology. 2013;154:4757–4767.
  13. Atsuchi K, Asakawa A, Ushikai M, et al. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport. 2010;21:1008–1011.
  14. Stengel A, Goebel M, Wang L, et al. Central nesfatin-1 red